Chester County News and Community Website
Immunome (NASDAQ: IMNM), headquartered in Exton, PA, is a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. Immunome’s proprietary discovery platform identifies novel therapeutic antibodies and their targets by leveraging highly educated components of the immune system, memory B cells, from patients whose bodies have learned to fight off their disease. For more information about the company, visit http://immunome.com.
EXTON, PA — Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics, announced that its discovery engine …
Read More
EXTON, PA — Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics, announced the release of findings from …
Read More EXTON, PA — Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics, with a focus on oncology …
Read More EXTON, PA — Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics, with a focus on oncology …
Read More EXTON, PA — Immunome, Inc. (Nasdaq: IMNM) recently announced the full exercise of the underwriters’ option to purchase an additional 487,500 shares of common stock at the public offering price …
Read More EXTON, PA — Immunome recently announced the appointments of Michael Diamond, MD, PhD, Jeffrey Henderson, MD, PhD, Shmuel Shoham, MD, and Susan Weiss, PhD, to its newly created COVID-19 Advisory …
Read More EXTON, PA — Immunome, a biotechnology company that harnesses the human B cell response to develop first-in-class therapeutics for oncology and infectious diseases, recently announced it has been awarded up …
Read More
EXTON, PA — Immunome, a biotechnology company focused on discovering first-in-class therapeutics by leveraging the most highly educated components of the human immune system from cancer patients, announced recently that …
Read More